JWM
CORT icon

JPL Wealth Management’s Corcept Therapeutics CORT Stock Holding History

JPL Wealth Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$807 Buy
+20
New +$748 ﹤0.01% 1264
2025
Q4 		– Sell
-20
Closed -$1.66K – 326
2025
Q3 		$1.66K Buy
+20
New +$1.45K ﹤0.01% 901

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

JPL Wealth Management's CORT Position: Q1 2026 in Review

JPL Wealth Management opened a new position in Corcept Therapeutics (CORT) in Q1 2026: 20 shares worth $807. The stake represents ﹤0.01% of the portfolio and ranks #1264 among its holdings. This is a return to the name: JPL Wealth Management previously reported a position in CORT as recently as Q3 2025.

JPL Wealth Management first reported a position in CORT in Q3 2025 and has held it in 2 quarters since. The position peaked at $1.66K in Q3 2025. 351 funds tracked by Wall St. Rank hold CORT as of Q1 2026.

  • JPL Wealth Management held 20 shares of Corcept Therapeutics worth $807 as of Q1 2026.
  • Corcept Therapeutics was a new JPL Wealth Management position in Q1 2026.
  • Corcept Therapeutics made up ﹤0.01% of JPL Wealth Management's portfolio in Q1 2026, its #1264 holding.
  • JPL Wealth Management first reported a position in Corcept Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • JPL Wealth Management's Corcept Therapeutics position peaked at $1.66K in Q3 2025.
  • 351 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.

Based on JPL Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.